Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crossover study of the relative bioavailability and food effect on lusutrombopag in healthy males
jRCT2080224619Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of lusutrombopag in Thrombocytopenia, sponsored by Shionogi & Co., Ltd. Primary endpoint: Primary pharmacokinetic endpoints. Started Mar 2019; status: completed.
02
Drugs
lusutrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on jRCT2080224619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224619.